Rhenman & Partners Asset Management AB raised its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 17.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 54,000 shares of the healthcare conglomerate’s stock after acquiring an additional 8,000 shares during the quarter. UnitedHealth […]
Rhenman & Partners Asset Management AB trimmed its stake in Humana Inc. (NYSE:HUM – Free Report) by 20.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,083 shares of the insurance provider’s stock after selling 9,917 shares during the period. […]
Rhenman & Partners Asset Management AB boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 165,000 shares of the medical research company’s stock after acquiring an additional 5,000 shares during […]
Rhenman & Partners Asset Management AB acquired a new stake in Repligen Co. (NASDAQ:RGEN – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 10,000 shares of the biotechnology company’s stock, valued at approximately $1,798,000. A number of other hedge […]
Rhenman & Partners Asset Management AB raised its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 3.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 58,672 shares of the biotechnology company’s stock after buying an additional 2,172 shares during […]